Skip to content

OPHTA-UCCLE

Active
Private limited companyfounded 2017active for 8 yearsDieweg 186, 1180 Ukkel, BelgiumKBO/BCE: BE 0684.949.464
Summary

OPHTA-UCCLE has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €34,466 and a net result of €124,559. Equity has been growing by about 9.5% per year since 2018. Its solvency ranks better than 22% of 3,033 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 23-11-2017 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.270.095.255 1180 Ukkel, since 23-11-2017
Financial year end
31 December
Peppol
Reachable since 15-03-2026

Board and ownership

Board

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€163,028
▲ 6.1%
Turnover
≈ €300,000
estimated
Profit
€124,559
▲ 11.2%
Equity
€34,466
▲ 13.0%
Total assets
€156,615
▲ 8.0%
Score breakdownraises risk1 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.02, cash €90,953Size: total assets €156,615Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 48% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 47+1
equity 22.0% of total assets
Liquidity 58+1
short-term debt 78.0% · cash 58.1%
Profitability 100=
return on assets 79.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €3,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.02 (1.13 in 2024), below the usual 1.5. Short-term debt is 78% and cash 58.1% of total assets. 78% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 21% of them on solvency, 34% on liquidity, 80% on profitability and 56% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.02, cash €90,953
NBB · annual accounts
lowers risk · Size: total assets €156,615
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · 1 of the last 3 accounts late
NBB · filings
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 3033 sector peers (2025).
NBB · sector comparison
Position among 3033 sector peers
Solvency
better than 22%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
on the day
2024
31 days late
2023
1 day early
2022
30 days late
2021
21 days late
2020
96 days late
2019
10 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 24 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Less equity than 84% of companies in human healthsector median €366,650 · 3,033 companies €34,466 View
  • Positive: 8 profitable years in a rowprofit 2025: €124,559 8 years View

Recent changes

  1. · Gazette deed Change of role: JANSSENS Sarah, from manager to director
  2. · Gazette deed Incorporation
All 11 events

Comparable companies

These companies have the same main activity as OPHTA-UCCLE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €150,000 and €174,000, founded between 2017 and 2018.

CompanyTotal assetsGross margin
OPHTA-UCCLE Ukkel€156,615€163,028
ACORD MED SPRL Brussel€173,576€154,105
Dr. Peeters Valérie - Dermatologie Diepenbeek€149,828€170,699
Dr. Alexander Clarysse Kortrijk€166,743€164,634
DOKTER TINE CORNELIS Oud-Heverlee€150,897€169,502
DR. CARTON CHRISTIAN, BEDRIJFSARTS Merchtem€157,039€150,822
Dokter Julie BASTIN Rotselaar€158,371€174,415
Full comparison

Key facts about OPHTA-UCCLE

What is the company number of OPHTA-UCCLE?
The company number of OPHTA-UCCLE is 0684.949.464. The VAT number is the same number with BE in front: BE 0684.949.464.
Where is OPHTA-UCCLE based?
The registered office is at Dieweg 186, 1180 Ukkel.Company details
What does OPHTA-UCCLE do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of OPHTA-UCCLE?
The legal form of OPHTA-UCCLE is Private limited company (BV).
When was OPHTA-UCCLE founded?
OPHTA-UCCLE was founded on 23-11-2017.
Is OPHTA-UCCLE still active?
Yes, OPHTA-UCCLE is an active enterprise in the KBO register.
What is the turnover of OPHTA-UCCLE?
The turnover in financial year 2025 is ≈ €300,000. This figure is estimated from the gross margin of €163,028 and 42 comparable companies (NACE 86220). It probably lies between €260,000 and €400,000.Financials
Is OPHTA-UCCLE profitable?
In financial year 2025, OPHTA-UCCLE made a profit of €124,559.
Where can I find the annual accounts of OPHTA-UCCLE?
OPHTA-UCCLE filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of OPHTA-UCCLE due?
OPHTA-UCCLE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.